BEUDAMED
    FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

    Stimulator, Invasive Bone Growth

    PMA: P790005 · Supplement: S067 · Decision Feb 17, 2021
    View on FDA
    Classifications
    1
    FEI Numbers
    5
    Registration Numbers
    5

    Basic Information

    Device Name
    Stimulator, Invasive Bone Growth
    Trade Name
    EBI OsteoGen Implantable Bone Growth Stimulators
    PMA Number
    P790005
    Supplement Number
    S067
    Device Class
    FDA Class 3
    Product Code
    LOE
    Generic Name
    Stimulator, invasive bone growth
    Medical Specialty
    Unknown
    Advisory Committee
    Orthopedic
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    February 17, 2021
    Date Received
    January 21, 2021
    Supplement Type
    30-Day Notice
    Supplement Reason
    Process Change - Manufacturer/Sterilizer/Packager/Supplier
    Expedited Review
    N

    Advisory Committee Statement

    Qualify and approve an alternate, proposed supplier to provide thermoformed PETG packaging trays and lids utilized in the final sterile pack assembly of EBI OsteoGen Surgically Implantable Bone Growth Stimulators and SpF Implantable Spinal Fusion Stimulators.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    LOE Stimulator, Invasive Bone Growth